-
Efficient Synthesis of Deuterium-Labeled Degarelix Acetate:
2026-05-09
This study introduces an efficient, 13-step protocol for synthesizing deuterium-labeled degarelix acetate, a critical internal standard for pharmacokinetic and metabolic studies of androgen receptor antagonists. The work details key innovations in deuterium incorporation and peptide assembly, providing a robust foundation for both clinical and mechanistic research in metabolic and endocrine fields.
-
Perphenazine: Dopamine D2 Receptor Antagonist in Advanced Re
2026-05-08
Perphenazine, a high-affinity dopamine D2 receptor antagonist, empowers neuropharmacology and host-pathogen studies with its unique dual action—inducing mitochondria-mediated cell death and enhancing macrophage antibacterial activity. Learn how APExBIO's rigorously characterized Perphenazine supports reproducible workflows, innovative assay design, and data-driven optimization.
-
Photothermal Therapy and CD47 Blockade Synergy in OSCC
2026-05-07
The referenced study demonstrates that combining photothermal therapy with CD47 blockade significantly augments macrophage-mediated tumor clearance in oral squamous cell carcinoma. Mechanistically, this synergy is mediated by immunogenic cell death and extracellular matrix remodeling, offering a dual approach to overcoming immune evasion and physical barriers in solid tumors.
-
SP600125 in JNK Pathway Research: Precision, Selectivity, an
2026-05-07
Explore the advanced scientific basis and unique assay optimization strategies enabled by SP600125, a highly selective JNK inhibitor. This article reveals new insights for apoptosis and inflammation research, building on recent kinase translation discoveries.
-
Phenothiazines Enhance Macrophage Antibacterial Defenses via
2026-05-06
This study reveals that phenothiazines, including perphenazine, enhance macrophage antibacterial activity by inducing reactive oxygen species (ROS) and autophagy, offering a new host-directed strategy against intracellular pathogens. The findings clarify key mechanistic pathways, informing research on antimicrobial resistance and host-pathogen interactions.
-
Neuroimaging Maturation of Dopamine Neurons in Parkinson’s M
2026-05-06
Goggi et al. (2020) demonstrate that dopamine transporter (DAT) neuroimaging can reliably assess the in vivo maturation of transplanted human embryonic stem cell-derived midbrain dopaminergic neurons in a preclinical model of Parkinson’s disease. This approach provides critical, non-invasive insights into cell therapy efficacy and dopaminergic neuron integration.
-
Mac-1 Deficiency Mitigates Cardiac Remodeling via Macrophage
2026-05-05
This study uncovers how Mac-1 (CD11b/CD18) deficiency reduces pressure overload-induced cardiac remodeling and heart failure by limiting macrophage infiltration and polarization. The findings highlight Mac-1 as a regulator of inflammatory responses in cardiac pathology and suggest potential therapeutic avenues targeting leukocyte adhesion and signaling.
-
Ruxolitinib Phosphate Induces Apoptosis in Anaplastic Thyroi
2026-05-05
This study demonstrates that Ruxolitinib phosphate (INCB018424) induces apoptosis and pyroptosis in anaplastic thyroid carcinoma (ATC) cells by inhibiting DRP1-mediated mitochondrial fission via transcriptional suppression downstream of JAK1/2-STAT3 signaling. The findings highlight a novel mechanism linking JAK/STAT pathway modulation with mitochondrial dynamics, offering new avenues for targeted ATC research.
-
Talabostat Mesylate (PT-100): Protocol Advances in Tumor Mic
2026-05-04
Talabostat mesylate (PT-100) stands out as a dual DPP4 and FAP inhibitor, enabling precise modulation of the tumor microenvironment and immune response. This guide provides stepwise workflows, key troubleshooting strategies, and insights on leveraging Talabostat mesylate for advanced cancer and hematopoiesis studies.
-
In Vitro Evaluation of Drug Responses in Cancer: New Metrics
2026-05-04
This dissertation introduces refined in vitro methods to distinguish between proliferative arrest and cell death when evaluating anti-cancer drugs. By dissecting growth inhibition and cytotoxicity with greater precision, the research offers a more nuanced understanding of drug response dynamics, with implications for both assay development and interpretation in cancer biology.
-
Bortezomib (PS-341): Applied Workflows for Cancer Research
2026-05-03
Bortezomib (PS-341) empowers researchers to dissect proteasome-regulated pathways and apoptosis in cancer models with unmatched precision. This guide delivers actionable experimental workflows, advanced troubleshooting, and strategic insights—bridging cutting-edge bench science with robust, reproducible results.
-
nor-Binaltorphimine Dihydrochloride in κ-Opioid Antagonist A
2026-05-02
nor-Binaltorphimine dihydrochloride empowers precise dissection of κ-opioid receptor function, enabling advanced studies in pain modulation and neural circuitry. This guide translates recent circuit-level research into actionable workflows, troubleshooting tips, and protocol enhancements for reproducible opioid receptor antagonist assays.
-
Sunitinib Sensitization Strategies: Ferroptosis and RCC Rese
2026-05-02
Explore how Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, advances renal cell carcinoma research through ferroptosis-based sensitization and apoptosis induction. Discover unique mechanistic insights grounded in recent breakthrough findings.
-
Prednisone: Mechanisms, Evidence, and Research Integration
2026-05-01
Prednisone, a synthetic corticosteroid, exerts immunosuppressive effects by arresting lymphocytes in the G1 phase and promoting apoptosis, particularly in CD8+ T cells. Its solubility, storage, and neurodegenerative impact in animal models are well-characterized, making it indispensable for immunology and neurodegeneration research.
-
ECL Chemiluminescent Substrate Detection Kit: Precision West
2026-04-30
The ECL Chemiluminescent Substrate Detection Kit from APExBIO enables ultrasensitive, reproducible Western blot chemiluminescence detection for protein and nucleic acid assays. Leverage its streamlined workflow and robust troubleshooting guidance to accelerate discovery in oncology, immunology, and translational research.
454 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page